Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017950HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059146HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059148HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059150HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059149HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059147HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10060220HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TCGA Plot Options
Drug Information
GeneORM1
DrugBank IDDB00281
Drug NameLidocaine
Target IDBE0000925
UniProt IDP02763
Regulation Type
PubMed IDs8946472
CitationsHerve F, Duche JC, d'Athis P, Marche C, Barre J, Tillement JP: Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein. Pharmacogenetics. 1996 Oct;6(5):403-15.
GroupsApproved; Vet_approved
Direct Classificationm-Xylenes
SMILESCCN(CC)CC(=O)NC1=C(C)C=CC=C1C
PathwaysLidocaine (Antiarrhythmic) Action Pathway; Lidocaine (Local Anaesthetic) Metabolism Pathway; Lidocaine (Local Anaesthetic) Action Pathway
PharmGKBPA450226
ChEMBLCHEMBL79